Artículos de revistas sobre el tema "Cxcr1-2"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Cxcr1-2".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Zhang, Jing, Shouguo Huang, Lini Quan, Qiu Meng, Haiyan Wang, Jie Wang y Jin Chen. "Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis". BioMed Research International 2021 (19 de marzo de 2021): 1–13. http://dx.doi.org/10.1155/2021/8883800.
Doroshenko, Tatyana, Yuri Chaly, Valery Savitskiy, Olga Maslakova, Anna Portyanko, Irina Gorudko y Nikolai N. Voitenok. "Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2". Blood 100, n.º 7 (1 de octubre de 2002): 2668–71. http://dx.doi.org/10.1182/blood.100.7.2668.
Konrad, F. M. y J. Reutershan. "CXCR2 in Acute Lung Injury". Mediators of Inflammation 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/740987.
Feniger-Barish, Rotem, Dan Belkin, Alon Zaslaver, Shira Gal, Mally Dori, Maya Ran y Adit Ben-Baruch. "GCP-2–induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR+-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling". Blood 95, n.º 5 (1 de marzo de 2000): 1551–59. http://dx.doi.org/10.1182/blood.v95.5.1551.005a36_1551_1559.
Smithson, Alex, Maria Rosa Sarrias, Juanjo Barcelo, Belen Suarez, Juan Pablo Horcajada, Sara Maria Soto, Alex Soriano et al. "Expression of Interleukin-8 Receptors (CXCR1 and CXCR2) in Premenopausal Women with Recurrent Urinary Tract Infections". Clinical Diagnostic Laboratory Immunology 12, n.º 12 (diciembre de 2005): 1358–63. http://dx.doi.org/10.1128/cdli.12.12.1358-1363.2005.
Molczyk, Caitlin y Rakesh K. Singh. "CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors". Biomedicines 11, n.º 2 (16 de febrero de 2023): 576. http://dx.doi.org/10.3390/biomedicines11020576.
Ngo, Hai, Evdoxia Hatjiharissi, Xavier Leleu, Judith Runnels, Anne-Sophie Moreau, Xiaoying Jia, Garrett O’Sullivan et al. "The CXCR4/SDF-1 Axis Regulates Migration and Adhesion in Waldenstrom Macroglobulinemia." Blood 108, n.º 11 (1 de noviembre de 2006): 2418. http://dx.doi.org/10.1182/blood.v108.11.2418.2418.
Khandaker, Masud H., Luoling Xu, Rahbar Rahimpour, Gordon Mitchell, Mark E. DeVries, J. Geoffrey Pickering, Sharwan K. Singhal, Ross D. Feldman y David J. Kelvin. "CXCR1 and CXCR2 Are Rapidly Down-Modulated by Bacterial Endotoxin Through a Unique Agonist-Independent, Tyrosine Kinase-Dependent Mechanism". Journal of Immunology 161, n.º 4 (15 de agosto de 1998): 1930–38. http://dx.doi.org/10.4049/jimmunol.161.4.1930.
Vacchini, Alessandro, Anneleen Mortier, Paul Proost, Massimo Locati, Mieke Metzemaekers y Elena Borroni. "Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties". International Journal of Molecular Sciences 19, n.º 12 (27 de noviembre de 2018): 3768. http://dx.doi.org/10.3390/ijms19123768.
Burton, Victoria J., Alan M. Holmes, Loredana I. Ciuclan, Alexander Robinson, Jan S. Roger, Gabor Jarai, Andrew C. Pearce y David C. Budd. "Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II". Blood 118, n.º 17 (27 de octubre de 2011): 4750–58. http://dx.doi.org/10.1182/blood-2011-05-347393.
Browning, Darren D., Wade C. Diehl, Matthew H. Hsu, Ingrid U. Schraufstatter y Richard D. Ye. "Autocrine regulation of interleukin-8 production in human monocytes". American Journal of Physiology-Lung Cellular and Molecular Physiology 279, n.º 6 (1 de diciembre de 2000): L1129—L1136. http://dx.doi.org/10.1152/ajplung.2000.279.6.l1129.
Inngjerdingen, Marit, Bassam Damaj y Azzam A. Maghazachi. "Expression and regulation of chemokine receptors in human natural killer cells". Blood 97, n.º 2 (15 de enero de 2001): 367–75. http://dx.doi.org/10.1182/blood.v97.2.367.
de Jong, Madelon M. E., Cathelijne Fokkema, Natalie Papazian, Sabrin Tahri, Zoltan Kellermayer, Michael Vermeulen, Mark van Duin et al. "Inflammasome-Primed Myeloid Cells Maintain a Pro-Tumor Microenvironment in Multiple Myeloma". Blood 138, Supplement 1 (5 de noviembre de 2021): 2679. http://dx.doi.org/10.1182/blood-2021-150327.
Troppan, Katharina, Kerstin Wenzl, Peter Neumeister, Christine Beham-Schmid, Martina Przekopowitz, Hildegard T. Greinix, Helmut Schaider y Alexander JA Deutsch. "The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome". Blood 126, n.º 23 (3 de diciembre de 2015): 3890. http://dx.doi.org/10.1182/blood.v126.23.3890.3890.
Teijeira, Alvaro, Saray Garasa, Itziar Migueliz, Assunta Cirella y Ignacio Melero. "755 CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A803. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0755.
Bie, Yaqin, Wei Ge, Zhibin Yang, Xianshuo Cheng, Zefeng Zhao, Shengjie Li, Wenchao Wang et al. "The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis". Disease Markers 2019 (20 de noviembre de 2019): 1–12. http://dx.doi.org/10.1155/2019/8023460.
Ullman, Nicholas A., Luis I. Ruffolo, Katherine M. Jackson, Alexander Chacon, Mary Georger, Rachel Jewell, Brian A. Belt, Dean Maeda, John Zebala y David Linehan. "CXCR1/2 blockade to enhance response to immune checkpoint inhibition in an aggressive orthotopic pancreatic adenocarcinoma model." Journal of Clinical Oncology 38, n.º 5_suppl (10 de febrero de 2020): 19. http://dx.doi.org/10.1200/jco.2020.38.5_suppl.19.
Molczyk, Caitlin, Elizabeth Thomas, Lubaba Zaman, Paran Goel y Rakesh K. Singh. "Abstract 894: CXCR1: A novel therapeutic avenue for CSC-like phenotypes in pancreatic ductal adenocarcinoma". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 894. http://dx.doi.org/10.1158/1538-7445.am2022-894.
Stadlbauer, V., R. P. Mookerjee, G. A. K. Wright, N. A. Davies, G. Jürgens, S. Hallström y R. Jalan. "Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis". American Journal of Physiology-Gastrointestinal and Liver Physiology 296, n.º 1 (enero de 2009): G15—G22. http://dx.doi.org/10.1152/ajpgi.90512.2008.
Takata, Hiroshi, Takuya Naruto y Masafumi Takiguchi. "Functional heterogeneity of human effector CD8+ T cells". Blood 119, n.º 6 (9 de febrero de 2012): 1390–98. http://dx.doi.org/10.1182/blood-2011-03-343251.
Мурашко, Д. И., А. Д. Таганович y Н. Н. Ковганко. "Combined Determination of CXCR1, CXCR2, Hyaluronic Acid and CYFRA 21-1 Receptors in the Blood in the Diagnosis of Non-Small Cell Lung Cancer". Евразийский онкологический журнал, n.º 3 (1 de noviembre de 2022): 201–16. http://dx.doi.org/10.34883/pi.2022.10.3.014.
Petering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp y Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils". Blood 93, n.º 2 (15 de enero de 1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.
Petering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp y Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils". Blood 93, n.º 2 (15 de enero de 1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.402k31_694_702.
Le Naour, Augustin, Mélissa Prat, Benoît Thibault, Renaud Mével, Léa Lemaitre, Hélène Leray, Marie-Véronique Joubert et al. "Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors". Journal of Molecular Cell Biology 12, n.º 3 (3 de septiembre de 2019): 202–15. http://dx.doi.org/10.1093/jmcb/mjz090.
Таганович, А. Д., Н. Н. Ковганко, Г. Л. Гуревич, Г. К. Новская, О. А. Будник, О. В. Готько y В. И. Прохорова. "Verification of Blood Inflammatory Biomarkers Changes in the Diagnosis of Non-Small Cell Lung Cancer". Евразийский онкологический журнал 12, n.º 1 (25 de marzo de 2024): 64–72. http://dx.doi.org/10.34883/pi.2024.12.1.024.
Cho, Hee Seong, Young In Choi, Seon Uk Park, Yi Seul Han, Jean Kwon y Sung Jun Jung. "Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2". International Journal of Molecular Sciences 24, n.º 3 (17 de enero de 2023): 1855. http://dx.doi.org/10.3390/ijms24031855.
Xing, Dongqi, J. Michael Wells, Samantha S. Giordano, Wenguang Feng, Amit Gaggar, Jie Yan, Fadi G. Hage, Li Li, Yiu-Fai Chen y Suzanne Oparil. "Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury". Journal of Applied Physiology 127, n.º 2 (1 de agosto de 2019): 444–56. http://dx.doi.org/10.1152/japplphysiol.00587.2018.
Wolf, Marlene, Maria Belen Delgado, Simon A. Jones, Beatrice Dewald, Ian Clark-Lewis y Marco Baggiolini. "Granulocyte chemotactic protein 2 acts via both IL- 8 receptors, CXCR1 and CXCR2". European Journal of Immunology 28, n.º 1 (enero de 1998): 164–70. http://dx.doi.org/10.1002/(sici)1521-4141(199801)28:01<164::aid-immu164>3.0.co;2-s.
Liu, Qian, Anping Li, Yijun Tian, Jennifer D. Wu, Yu Liu, Tengfei Li, Yuan Chen, Xinwei Han y Kongming Wu. "The CXCL8-CXCR1/2 pathways in cancer". Cytokine & Growth Factor Reviews 31 (octubre de 2016): 61–71. http://dx.doi.org/10.1016/j.cytogfr.2016.08.002.
Blaser, Bradley Wayne, Jessica Moore, Brian LI, Owen J. Tamplin, Vera Binder y Leonard I. Zon. "IL-8 and CXCR1 Remodel the Vascular Niche to Promote Hematopoietic Stem and Progenitor Cell Engraftment". Blood 126, n.º 23 (3 de diciembre de 2015): 783. http://dx.doi.org/10.1182/blood.v126.23.783.783.
Penco-Campillo, Manon, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco et al. "Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas". Cells 11, n.º 23 (5 de diciembre de 2022): 3933. http://dx.doi.org/10.3390/cells11233933.
Lee, Kyung-Soon, Edelmar Navaluna, Nicole M. Marsh, Eric M. Janezic y Chris Hague. "Development of a Novel SNAP-Epitope Tag/Near-Infrared Imaging Assay to Quantify G Protein-Coupled Receptor Degradation in Human Cells". SLAS DISCOVERY: Advancing the Science of Drug Discovery 26, n.º 4 (5 de enero de 2021): 570–78. http://dx.doi.org/10.1177/2472555220979793.
Laura, Brandolini, Benedetti Elisabetta, Ruffini Pier Adelchi, Russo Roberto, Cristiano Loredana, Antonosante Andrea, d’Angelo Michele et al. "CXCR1/2 pathways in paclitaxel-induced neuropathic pain". Oncotarget 8, n.º 14 (20 de febrero de 2017): 23188–201. http://dx.doi.org/10.18632/oncotarget.15533.
Pawlick, Rena L., John Wink, Andrew R. Pepper, Antonio Bruni, Nasser Abualhassen, Yasmin Rafiei, Boris Gala-Lopez, Mariusz Bral y A. M. James Shapiro. "Reparixin, a CXCR1/2 inhibitor in islet allotransplantation". Islets 8, n.º 5 (21 de junio de 2016): 115–24. http://dx.doi.org/10.1080/19382014.2016.1199303.
Lima, Leonardo R. de, Heloisa M. F. Mendes, Frederico M. Soriani, Danielle G. de Souza, Geraldo Eleno S. Alves, Mauro M. Teixeira y Rafael R. Faleiros. "Histologic and inflammatory lamellar changes in horses with oligofructose-induced laminitis treated with a CXCR1/2 antagonist". Pesquisa Veterinária Brasileira 36, n.º 1 (enero de 2016): 13–18. http://dx.doi.org/10.1590/s0100-736x2016000100002.
Henrot, Pauline, Renaud Prevel, Patrick Berger y Isabelle Dupin. "Chemokines in COPD: From Implication to Therapeutic Use". International Journal of Molecular Sciences 20, n.º 11 (6 de junio de 2019): 2785. http://dx.doi.org/10.3390/ijms20112785.
Ghasemzadeh, Mehran, Zane S. Kaplan, Imala Alwis, Simone M. Schoenwaelder, Katrina J. Ashworth, Erik Westein, Ehteramolsadat Hosseini et al. "The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi". Blood 121, n.º 22 (30 de mayo de 2013): 4555–66. http://dx.doi.org/10.1182/blood-2012-09-459636.
Wong, Yin Ping, Noorhafizah Wagiman, Jonathan Wei De Tan, Barizah Syahirah Hanim, Muhammad Syamil Hilman Rashidan, Kai Mun Fong, Naufal Naqib Norhazli et al. "Loss of CXC-Chemokine Receptor 1 Expression in Chorioamnionitis Is Associated with Adverse Perinatal Outcomes". Diagnostics 12, n.º 4 (1 de abril de 2022): 882. http://dx.doi.org/10.3390/diagnostics12040882.
Mekhloufi, Abdelilah, Andrea Kosta, Helena Stabile, Rosa Molfetta, Alessandra Zingoni, Alessandra Soriani, Marco Cippitelli et al. "Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor". Cancers 12, n.º 2 (13 de febrero de 2020): 440. http://dx.doi.org/10.3390/cancers12020440.
Lippert, Undine, Metin Artuc, Andreas Grützkau, Annelie Möller, Anna Kenderessy-Szabo, Dirk Schadendorf, Johannes Norgauer et al. "Expression and Functional Activity of the IL-8 Receptor Type CXCR1 and CXCR2 on Human Mast Cells". Journal of Immunology 161, n.º 5 (1 de septiembre de 1998): 2600–2608. http://dx.doi.org/10.4049/jimmunol.161.5.2600.
Castelli, Vanessa, Laura Brandolini, Michele d’Angelo, Cristina Giorgio, Margherita Alfonsetti, Pasquale Cocchiaro, Francesca Lombardi, Annamaria Cimini y Marcello Allegretti. "CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling". Cells 10, n.º 9 (6 de septiembre de 2021): 2324. http://dx.doi.org/10.3390/cells10092324.
Citro, Antonio, Elisa Cantarelli, Paola Maffi, Rita Nano, Raffaella Melzi, Alessia Mercalli, Erica Dugnani et al. "CXCR1/2 inhibition enhances pancreatic islet survival after transplantation". Journal of Clinical Investigation 122, n.º 10 (1 de octubre de 2012): 3647–51. http://dx.doi.org/10.1172/jci63089.
Lima, Leonardo R., Heloisa M. Falcão Mendes, Frederico M. Soriani, Geraldo Eleno S. Alves, Danielle G. de Souza, Mauro M. Teixeira y Rafael R. Faleiros. "Reparixin, an antagonist of CXCR1/2, in experimental laminitis". Journal of Equine Veterinary Science 33, n.º 10 (octubre de 2013): 871–72. http://dx.doi.org/10.1016/j.jevs.2013.08.055.
Lu, Min, Lijuan Xia, Mohamed E. Salama y Ronald Hoffman. "Enriched Populations of Human Megakaryocytic Cells Affect the Behavior of Myelofibrosis CD34+ Cells As Well As Cells Belonging to the MF Supportive Microenvironment". Blood 132, Supplement 1 (29 de noviembre de 2018): 3057. http://dx.doi.org/10.1182/blood-2018-99-117062.
Armstrong, Chris, Jonathan Coulter, Pamela Maxwell, Silvia Berlingeri, Joe M. O'Sullivan, Kevin Prise y David J. Waugh. "Sensitivity of PTEN-deficient prostate carcinoma cells to ionizing radiation through inhibition of treatment-induced CXCL8 signaling." Journal of Clinical Oncology 31, n.º 6_suppl (20 de febrero de 2013): 154. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.154.
Kaur, Manpreet, Ramneek, C. S. Mukhopadhyay y Jaspreet Singh Arora. "PCR-SSCP and Sequencing of CXCR1 (IL8RA) Gene in Indian Water Buffalo". International Journal of Applied Sciences and Biotechnology 4, n.º 2 (27 de junio de 2016): 228–32. http://dx.doi.org/10.3126/ijasbt.v4i2.15128.
Ruffini, P. A., L. Brandolini, R. Russo, A. Cimini y M. Allegretti. "CXCR1/2 inhibition prevents paclitaxel- and oxaliplatin-induced peripheral neuropathy". European Journal of Cancer 69 (diciembre de 2016): S115. http://dx.doi.org/10.1016/s0959-8049(16)32943-4.
Carreira, E. U., V. Carregaro, M. M. Teixeira, A. Moriconi, A. Aramini, W. A. Verri, S. H. Ferreira, F. Q. Cunha y T. M. Cunha. "Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain". European Journal of Pain 17, n.º 5 (7 de noviembre de 2012): 654–63. http://dx.doi.org/10.1002/j.1532-2149.2012.00240.x.
Huang, Yunjia, Jichen Yang, Yong Zhang, Shuhong Kuang, Zongshan Shen y Wei Qin. "Blocking CXCR1/2 attenuates experimental periodontitis by suppressing neutrophils recruitment". International Immunopharmacology 128 (febrero de 2024): 111465. http://dx.doi.org/10.1016/j.intimp.2023.111465.
Florey, Oliver J., Michael Johns, Olubukola O. Esho, Justin C. Mason y Dorian O. Haskard. "Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between FcγRIIa and CXCR1/2". Blood 109, n.º 9 (23 de enero de 2007): 3881–89. http://dx.doi.org/10.1182/blood-2006-08-044669.